Dapagliflozin Improves Mitochondrial Function to Reduce the Risk of Atrial Fibrillation in a High‐Glucose Environment by Activating the AMPK/PGC‐1α/SIRT3 Signalling Pathway

Clinical and Experimental Pharmacology and Physiology · Published 2026-06-30 · DOI 10.1111/1440-1681.70143

Authors (6)

Xingxing Li, Guibing He, Fen Zhang, Jie Wu, Shu Chen, Yang Dong

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Li, X., He, G., Zhang, F., et al. (2026). Dapagliflozin Improves Mitochondrial Function to Reduce the Risk of Atrial Fibrillation in a High‐Glucose Environment by Activating the AMPK/PGC‐1α/SIRT3 Signalling Pathway. Clinical and Experimental Pharmacology and Physiology. https://doi.org/10.1111/1440-1681.70143

Related articles